Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 4.81 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 11, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 40,000 shares of its common stock on Oct 11, with a total market value of approximately $4.81 million.
Pfizer, BioNTech's Updated Covid-19 Vaccine Approved in UK for Adults
Express News | UK's Mhra: Approved an Adapted Pfizer/BioNTech Covid-19 Vaccine (Comirnaty) That Targets the Kp.2 Covid-19 Subvariant for Adults
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
UK Considers GBP129 Million Subsidy for BioNTech to Secure Investment
UK Court Sides With Pfizer, BioNTech in MRNA Patent Case Against CureVac
